About NEXT Life Sciences
NEXT Life Sciences is a company based in San Luis Obispo (United States) founded in 2021 by L R Fox.. NEXT Life Sciences has raised $4.05 million across 2 funding rounds from investors including StartUp Health, The Family and Transform VC. NEXT Life Sciences offers products and services including Reproductive Healthcare Solutions and Information and Trials. NEXT Life Sciences operates in a competitive market with competitors including Esprit Pharma, Lipella, Regenfro Co, Kissei Pharmaceutical and TheraVida, among others.
- Headquarter San Luis Obispo, United States
- Founders L R Fox
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Next Life Sciences, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.05 M (USD)
in 2 rounds
-
Latest Funding Round
$2.5 M (USD), Seed
Jan 16, 2024
-
Investors
StartUp Health
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NEXT Life Sciences
NEXT Life Sciences offers a comprehensive portfolio of products and services, including Reproductive Healthcare Solutions and Information and Trials. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers support and resources for couples in family planning.
Provides details on reproductive health trials and inquiries.
Funding Insights of NEXT Life Sciences
NEXT Life Sciences has successfully raised a total of $4.05M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2.5 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $2.5M
-
First Round
First Round
(05 Jun 2023)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Seed - NEXT Life Sciences | Valuation | The Family , Transform VC | |
| Jun, 2023 | Amount | Seed - NEXT Life Sciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NEXT Life Sciences
NEXT Life Sciences has secured backing from 9 investors, including venture fund and angel investors. Prominent investors backing the company include StartUp Health, The Family and Transform VC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
An accelerator focused on empowering pre-seed startup founders.
|
Founded Year | Domain | Location | |
|
Early-stage technology companies are funded by Transform VC.
|
Founded Year | Domain | Location | |
|
Online information platform of health and wellness
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NEXT Life Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NEXT Life Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Next Life Sciences Comparisons
Competitors of NEXT Life Sciences
NEXT Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Esprit Pharma, Lipella, Regenfro Co, Kissei Pharmaceutical and TheraVida, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Develop drugs for genitourinary (GU) disorders
|
|
| domain | founded_year | HQ Location |
Lipid-based therapies for common bladder syndromes are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics to treat renal diseases
|
|
| domain | founded_year | HQ Location |
Therapies for renal diseases and urology-related anemia are developed.
|
|
| domain | founded_year | HQ Location |
Clinical stage biopharma company developing drugs for urology and central nervous system disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Next Life Sciences
Frequently Asked Questions about NEXT Life Sciences
When was NEXT Life Sciences founded?
NEXT Life Sciences was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is NEXT Life Sciences located?
NEXT Life Sciences is headquartered in San Luis Obispo, United States. It is registered at San Luis Obispo, California, United States.
Who is the current CEO of NEXT Life Sciences?
L R Fox is the current CEO of NEXT Life Sciences. They have also founded this company.
Is NEXT Life Sciences a funded company?
NEXT Life Sciences is a funded company, having raised a total of $4.05M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.55M, raised on Jun 05, 2023.
What does NEXT Life Sciences do?
NEXT Life Sciences was founded in 2021 in San Luis Obispo, United States, focusing on the biotechnology sector for reproductive health. Non-hormonal, reversible male contraception methods are provided through the Plan A procedure, which utilizes Vasalgel to block sperm transport in the vas deferens without permanent severance, as seen in traditional vasectomies. Operations center on advancing these minimally invasive options for family planning.
Who are the top competitors of NEXT Life Sciences?
NEXT Life Sciences's top competitors include Lipella, Kissei Pharmaceutical and Regenfro Co.
What products or services does NEXT Life Sciences offer?
NEXT Life Sciences offers Reproductive Healthcare Solutions and Information and Trials.
Who are NEXT Life Sciences's investors?
NEXT Life Sciences has 9 investors. Key investors include StartUp Health, The Family, Transform VC, Brock Pierce, and Pay It Forward Venture Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.